Skip to main content

Postgraduate Course in Cardiometabolic Medicine 2025

-
City
London, UK
Type of event
on site

 

Invitation

Dear Colleagues

It is a pleasure to announce the 2nd Postgraduate Course in Cardiometabolic Medicine, a timely and highly acclaimed educational programme conceived by Zurich Heart House – London Heart House, King’s College, and Royal Brompton & Harefield Hospitals, which will address an unmet educational need.

Cardiometabolic disorders represent a cluster of interrelated risk factors, primarily dyslipidemia, hypertension, elevated fasting blood glucose, obesity and non-alcoholic steatohepatitis. A combination of several of these risk factors massively increases the incidence and mortality of coronary heart disease and stroke. The strong association between metabolic disorders and cardiovascular health delivers a compelling reason to improve awareness of this cluster by identifying the risk factors and inducing targeted interventions.

The Postgraduate Course in Cardiometabolic Medicine consists of a three-day programme. State of the art lectures alternate with a great variety of interactive sessions, including workshops, rapid fire sessions and hands-on imaging sessions.

The course offers a unique opportunity to become an expert in the seminal area of cardiometabolic medicine. We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy three days of interactive education for the benefit of your practice and your patients.
Sincerely,

Andrew Krentz
Thomas F. Lüscher
Mahmoud Barbir
John E. Deanfield
Michael Papadakis
Naveed Sattar 


Scientific Programme

Day 1, Wednesday, March 19th, 2025

Venue: The Royal Society of Medicine

09:00 - 09:30 | REGISTRATION AND COFFEE
09:30 - 09:45 | Opening Session
09:30Welcome by the course directors & Course concept and structure 

 

09:45 - 11:30 | Session 1: Obesity I - Causes and mechanisms
Chairs: NN & Michael Papadakis
09:45Is obesity a disease? If so, how do we diagnose it? The ESC’s viewKonstantinos Koskinas, Berne
10:05Obesity and inflammationFiona McGillicuddy, Dublin
10:25What links adiposity to CVD?Naveed Sattar, Glasgow
10:45The gut microbiome: a new risk factor for obesity and CVDThomas F. Lüscher, London
11:05Panel discussion 
11:30 - 12:00 | COFFEE 

 

12:00 - 12:30 | Keynote lecture
 Medical management of obesity: GLP-1/GIP agonistsJohn E. Deanfield, London
12:30 - 13:30 | Session 2: Obesity II – Management 
Chairs: NN & Fiona McGillicuddy
12:30Behavioural management: Nutrition    Michael Lean, Glasgow 
12:50Bariatric surgery: is there still a role?Ahmed R. Ahmed, London
13:10Panel discussion 
13:30 - 14:30  |  LUNCH BREAK

 

14:30 - 16:00 | Session 3: ASCVD Assessment I
Chairs: Mahmoud Barbir & Thomas F. Lüscher
14:30

Cardiovascular risk assessment: the ESC SCORE/SCORE2-OP

The ESC Guidelines 

François Mach, Geneva
14:50 LDL-C and cardiovascular disease: Why is lower better?    Lale Tokgozolu, Ankara
15:10Lifetime risk: CVD prevention - personal and national strategyJohn E. Deanfield, London
15:30Panel discussion 
16:00 - 16:30 | COFFEE  
  
16:30 - 17:30 | Case-based interactive seminars I 
 How to assess adiposity: Clinical, MRI and beyondEsmeralda Capristo, Rome
 How to manage obesityPiya Sen Gupta, London

 

DAY 2, Thursday, March 20th, 2025

09:00 - 10:30 | Session 4: ASCVD Assessment II & Management
Chairs: Lale Tokgözoğlu & Riyaz Patel
09:00Multimodality imaging to assess ASCVDRebecca Scholfield, Peterborough
09:20Perivascular fat: Therapeutic target or surrogate of vascular disease?Charalambos Antoniades, Oxford
09:40Novel lipoproteins: Lipoprotein(a)     Ulf Landmesser, Berlin
10:00Remnant cholesterol and triglycerides in cardiovascular disease    Børge Nordestgaard, Copenhagen
10:20Panel discussion 
10:45 - 11:15 | COFFEE 

 

 
11:15 - 12:15 | Live demonstrations 
 Practical lipid apheresisMahmoud Barbir & Alison Pottle, London
 Pulse wave velocity and central blood pressure measurement – Practical demonstrationChristian Heiss, Guildford
12:15 - 13:00 | Industry Sponsored Symposium
13:00 – 13:45 | LUNCH BREAK and INTERACTIVE INDUSTRY EXHIBITION

 

13:45 - 15:10 | Session 5: Diabetes mellitus (DM) 
Chairs: Eleanor Wicks & William Alazawi
13:45Pathogenesis of type 2 DM     Janaka Karaliedde, London
14:05Diabetes Type 2 and CVD beyond glucocentricity    Stephan Jacob, Villingen
14:25 Management of CVD risk in type 2 diabetes – the 2023 ESC Diabetes guidelinesFrancesco Cosentino, Stockholm
14:45Panel discussion 

 

15:10 - 16:10 | Session 6: Nephrology - Chronic Kidney Disease (CKD) – Causes & Mechanisms  
Chairs: Beatriz Fernadez-Fernandez & Raj Thakkar
15:10CKD and cardiovascular risk    Parminder Judge, Oxford
15:30Albuminuria, eGFR slopes and outcomes: impact of pharmacotherapyDavid Wheeler, London
15:50Panel discussion 
16:10 - 16:30 | COFFEE

 

16:30 - 17:10 | Session 7: Nephrology - Chronic kidney disease (CKD) - Management 
Chairs: Thomas Lüscher & Parminder Judge
16:30SGLT2i and GLP1-RA in CKD and DKD – the 4 pillar approachBeatriz Fernendez-Fernandez, Madrid
16:50MR antagonists and CKD: effects and management of hyperkalaemiaFaiez Zannad, Nancy
17:10Panel discussion 
17:30 – 18:30  |  Case-based interactive seminars II
 Managing type 2 diabetes and CVD risk    Stephan Jacob, Villingen
 Managing patients with CKD    Beatriz Fernendez-Fernandez, Madrid

DAY 3, Friday, March 21st, 2025

09:00 - 10:00 | Session 8: Metabolic dysfunction-associated steatotic liver disease (MASLD) 
Chairs: Andrew Krentz & NN
09:00Screening and diagnosis of MASLD    Philip Newsome, London
09:20Management of MAFLDWilliam Alazawi, London
09:40Panel discussion 

 

10:00 - 11:00 | Session 9: Endocrinology and Cardiovascular disease 
Chairs: NN & Nikhant Sabharwal
10:00Cardiovascular risk in classic endocrine diseaseAdrian Heald, Manchester
10:20Sex hormones and CVD: Men vs Women    Andrew Krentz, London
10:40Panel discussion 
11:00 - 11:30 | COFFEE 

 

11:30 - 12:30 | Session 10: Amyloid heart disease 
Chairs: Eleanor Wicks & Nikant Sabharwal 
11:30The spectrum of amyloid heart diseaseAna Martinez Naharro, London
11:50Diagnosis and management of cardiac amyloidosisAna Martinez Naharro, London
12:10Panel discussion 
12:30 - 13:30 | LUNCH 

 

13:30 - 15:00 | Session 11: Heart failure  
Chairs: Eleanor Wicks & Shanti Velmurugan
 
13:30Prevention of heart failurePardeep Jhund, Glasgow 
13:50Comorbidities of heart failure: obesity, diabetes and renal failureSamuel Seidu, Leicester 
14:10Management of heart failure: the 2021 and 2023 ESC guidelines    Theresa McDonagh, London 
14:30Panel discussion  
15:00 - 15:30 | COFFEE  
    
15:30 – 16:30  |  Case-based interactive seminars III  
 Diagnosing MASLD with FibroscanWilliam Alazawi, London 
 Diagnosing heart failure with echocardiographyRajdeep Khattar, London 

The programme may be subject to change.


 

Faculty

Ahmed R. Ahmed
St. Mary's Hospital
London, UK

William Alazawi
Queen Mary University of London
London, UK

Charalambos Antoniades
University of Oxford
Oxford, UK

Mahmoud Barbir
Royal Brompton & Harefield Hospitals
London, UK

Esmeralda Capristo
Agostino Gemelli University Polyclinic 
(IRCCS) Rome, IT

Francesco Cosentino
Karolinska Institutet
Stockholm, SE

John E. Deanfield
University College London
London, UK

Beatriz Fernandez-Fernandez
IIS-Fundacion Jimenez Diaz UAM
Madrid, ES

Adrian Heald
University of Manchester
Manchester, UK

Christian Heiss
University of Surrey
Guildford, UK

Stephan Jacob
Practice for prevention and therapy
Villingen-Schwenningen, DE

Pardeep Jhund
University of Glasgow
Glasgow, UK

Parminder Judge
University of Oxford
Oxford, UK

Janaka Karalliedde
Guy’s and St Thomas’ Hospital 
London, UK

Rajdeep Khattar
Royal Brompton & Harefield Hospitals
London, UK

Konstantinos Koskinas
University hospital Berne - Inselspital
Berne,CH

Andrew Krentz
King’s College London
London, UK

Ulf Landmesser
Charite University Medicine Berlin
Berlin, DE

Michael Lean
University of Glasgow
Glasgow, UK

Thomas F. Lüscher
Royal Brompton & Harefield Hospitals
London, UK

François Mach
University hospital Geneva,
Geneva, CH

Ana Martinez Naharro
University College London
London, UK

Theresa McDonagh
King’s College Hospital
London, UK

Fiona McGillicuddy
University College Dublin
Dublin, IE

Philip Newsome
University of Birmingham
Birmingham, UK

Børge Nordestgaard
Copenhagen University Hospital
Copenhagen, DK

Michael Papadakis
St. George’s University Hospitals
London, UK

Riyaz Patel
University College London
London, UK

Alison Pottle
Royal Brompton & Harefield Hospitals
London, UK

Nikant Sabharwal
John Radcliffe Hospital
Oxford, UK

Naveed Sattar
University of Glasgow
Glasgow, UK

Rebecca Schofield
West Anglia NHS Foundation Trust
Peterborough, UK

Samuel Seidu
University of Leicester 
Leicester, UK

Piya Sen Gupta
Guy’s Hospital
London, UK

Raj Thakkar
Cardiff University Medical School
Cardiff, UK

Lale Tokgözoğlu
Hacettepe University
Ankara, TR

Shanti Velmurugan
Whipps Cross Hospital
London, UK

David C. Wheeler
University College London
London, UK

Eleanor Wicks
University of Oxford
Oxford, UK

Faiez Zannad
University of Lorraine
Nancy, FR
 


 

General Information

Registration

Category 
Registration fees 
Early registration fee (until February 18th, 2025 )GBP 400
Regular course feeGBP 450
Early registration fee (until February 18th, 2025 ): Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)*GBP 200
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)*GPB 250
Day TicketsGPB 150

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Christine Lohmann at christine.lohmann@zhh.ch

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Travel Information

Travel to London

You must have a valid passport to enter the UK. It should be valid for the whole of your stay. You may also need a visa, depending on which country you’re from and the reason for your stay. Check if you need a visa to come to the UK. You must have your visa before you travel to the UK.

Electronic travel authorisation (ETA) 

From 2 April 2025, EU citizens will require an Electronic Travel Authorisation (ETA) to enter the UK. For non-EU citizens, the regulation will come into force on 8 January 2025. More information can be found on https://www.gov.uk/guidance/apply-for-an-electronic-travel-authorisation-eta. It will be possible to apply for the ETA, which will be required from April, from 5 March 2025 onwards. For nationals of certain countries outside Europe, the ETA will be required from 8 January 2025. The application is again possible from 27 November 2024: https://www.gov.uk/guidance/check-when-you-can-get-an-electronic-travel-authorisation-eta. You won’t have to apply in case you have a VISA.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 15 will be charged for administrative costs. In case of cancellation up to March 1st, 2025, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.

Venue

The Royal Society of Medicine,
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom

 

Organisation

Zurich Heart House, / London Heart House, Foundation for Cardiovascular Research
Eleanor Wicks
Christine Lohmann
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95 
www.zhh.ch / www.londonhearthouse.uk 

 

Accreditation

The Postgraduate Course in Cardiometabolic Medicine has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 18 category 1 (external) CPD credit(s)

The Postgraduate Course in Cardiometabolic Medicine has been accredited 
by the European Accreditation Council for Continuing Medical Education (EACCME®)
for a maximum of 18.0 European CME credits (ECMEC®s)
 


 


Sponsors

Under the Auspices of

In collaboration with

Register here

Anmeldeschluss